Altered gonadal steroidogenesis in critical illness: Is treatment with anabolic steroids indicated?

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 15, Issue 4, 2001, Pages 479-494

  Spratt, Daniel I ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

Anabolic steroids; Androgens; Aromatase; Burns; Catabolism; Critical illness; Cytokines; Gonadotropin releasing hormone (GnRH); Hypogonadotropism; Luteinizing hormone (LH); Myocardial infarction; Oestrogens; Oxandrolone; Sepsis; Steroidogenic acute regulatory protein (StAR); Surgery; Testosterone; Wound healing

Indexed keywords

ANABOLIC AGENT; ANDROGEN; AROMATASE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DEXAMETHASONE; ESTRADIOL; ESTROGEN; GLUCOCORTICOID; GONADORELIN; GROWTH FACTOR; GROWTH HORMONE; LUTEINIZING HORMONE; NANDROLONE; OXANDROLONE; PLACEBO; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE; TESTOSTERONE DERIVATIVE;

AROMATIZATION; BURN; CATABOLISM; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INDICATION; ESTROGEN BLOOD LEVEL; EXPERIMENTAL ANIMAL; GENITAL SYSTEM; GONADOTROPIN RELEASE; HEART FUNCTION; HEART INFARCTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNE SYSTEM; LEYDIG CELL; NONHUMAN; PHYSIOLOGY; PREPUBERTY; REVIEW; SEPSIS; SIDE EFFECT; STEROIDOGENESIS; SURGICAL APPROACH; SURVIVAL; TESTOSTERONE BLOOD LEVEL; WOUND HEALING;

EID: 0035746479     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2001.0165     Document Type: Article

References (100)

1. The history of synthetic testosterone
2. Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection?
3. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial
4. Treatments for wasting in patients with the acquired immunodeficiency syndrome
5. Anabolic effects of nandrolone decanoate in patients receiving dialysis: A randomized controlled trial
6. Use of androgens in patients with renal failure
7. Anticatabolic and anabolic strategies in critical illness: A review of current treatment modalities
8. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns
9. Closure of the 'non-healing wound' corresponds with correction of weight loss using the anabolic agent oxandrolone
10. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury
11. The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent
12. Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat
13. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury
14. Oxandrolone in trauma patients
15. Anabolic effects of oxandrolone after severe burn
16. Influence of major surgical stress on plasma levels of testosterone, luteinizing hormone and follicle-stimulating hormone in male patients
17. Effects of general anaesthesia and severity of surgical stress on serum LH and testosterone in males
18. Effect of acute myocardial infarction on pituitary-testicular function
19. Effect of surgical stress on pituitary-testicular function
20. Endocrine response after burn
21. Leptin
22. Regulation of the acute production of steroids in steroidogenic cells
23. The insulin-like growth factor (IGF) system and gonadotropin regulation: Actions and interactions
24. Macrophages: Important accessory cells for reproductive function
25. Modulation of Leydig cell testosterone production by secretory products of macrophages
26. Testosterone and muscle protein metabolism
27. The influence of severe illness on gonadotropin secretion in the postmenopausal female
28. Hormonal dysregulations in severe burns
29. Transient hypogonadotropic hypogonadism caused by critical illness
30. Pituitary-testicular axis dysfunction in burned men
31. Mechanisms leading to hypogonadism in men with burns injuries
32. Elevated oestrogen and reduced testosterone levels in the serum of male septic shock patients
33. Central hypogonadism in burned men
34. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: Bio- and immunoactive gonadotropins
35. An investigation of LG pulsatility in burned men by bioassay and radioimmunoassay
36. Circulating immunoreactive inhibin and testosterone levels in men with critical illness
37. Reproductive axis suppression in acute illness is related to disease severity
38. Differential changes in serum concentrations of androgens and oestrogens (in relation with cortisol) in postmenopausal women with acute illness
39. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock
40. Endotoxin-induced changes in sex steroid hormone levels in male rats
41. Changes in serum concentrations of hormones that accompany acute illness are similar in rats and in humans
42. Stress-induced inhibition of reproductive functions: Role of endogenous corticotropin-releasing factor
43. Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey
44. Corticotropin-releasing factor and gonadotropin-releasing hormone pulse generator activity in the rhesus monkey. Electrophysiological studies
45. Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle
46. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade
47. Effect of human corticotropin-releasing hormone on gonadotropin secretion in cycling and postmenopausal women
48. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women
49. Cytokines and pituitary hormone secretion
50. Mechanism of action of interleukin-1 in modulating gonadotropin secretion. In vivo and in vitro studies
51. Interleukin-1 inhibits NMDA-stimulated GnRH secretion: Associated effects on the release of hypothalamic inhibitory amino acid neurotransmitters
52. Effect of bacterial endotoxin on in vivo pulsatile gonadotropin secretion in adult male rats
53. Effect of interleukin-1 beta on gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in castrated male rats
54. Effects of interleukins on secretion of luteinizing hormone from ovine pituitary cells
55. Relationship of serum cortisol and prolactin levels to the transient hypogonadism of acute illness
56. Leptin and interleukin-6 in sepsis
57. Leptin levels in protracted critical illness: Effects of growth hormone-secretagogues and thyrotropin-releasing hormone
58. Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock
59. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
60. Systemic cytokine response after major surgery
61. Treatment with preparations of human leukocyte interferon decreases serum testosterone concentrations in men
62. Dose-dependent effects of recombinant human interleukin-6 on the pituitary-testicular axis
63. The testicular effects of tumor necrosis factor
64. Interleukin-1 inhibits Leydig cell steroidogenesis in primary culture
65. Inhibitory actions interleukin-1 beta on steroidogenesis in primary cultures of neonatal rat testicular cells
66. The role of tumor necrosis factor-alpha in the regulation of mouse Leydig cell steroidogenesis
67. Tumor necrosis factor-alpha inhibition of 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) expression
68. Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 expression
69. Direct and indirect effects of murine interleukin-2, gamma interferon, and tumor necrosis factor on testosterone synthesis in mouse Leydig cells
70. Interferon-gamma inhibits steroidogenesis and accumulation of mRNA of the steroidogenic enzymes P450scc and P450c17 in cultured porcine Leydig cells
71. Recombinant murine tumor necrosis factor-alpha inhibits cholesterol side-chain cleavage cytochrome P450 and insulin-like growth factor-1 gene expression in rat Leydig cells
72. Human leukocyte interferon inhibits human chorionic gonadotropin stimulated testosterone production by porcine Leydig cells in culture
73. Tumor necrosis factor alpha inhibits gonadotropin action in cultured porcine Leydig cells: Site(s) of action
74. Interferon-gamma inhibits the steroidogenic acute regulatory protein messenger ribonucleic acid expression and protein levels in primary cultures of rat Leydig cells
75. Tumor necrosis factor-alpha inhibits Leydig cell steroidogenesis through a decrease in steroidogenic acute regulatory protein expression
76. Inhibitory effects of TNF alpha on mouse tumor Leydig cells: Possible role of ceramide in the mechanism of action
77. Interleukin-1 inhibits Leydig cell steroidogenesis without affecting steroidogenic acute regulatory protein messenger ribonucleic acid or protein levels
78. Low IGF-1 levels are often uncoupled with elevated GH levels in catabolic conditions
79. Aromatase activity in human adipose tissue stromal cells: The effect of fetal bovine serum fractions on dexamethasone-stimulated aromatization
80. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter
81. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes
82. The effect of glucocorticoids on the in vivo conversion of androstenedione to oestrone
83. Peripheral aromatization: Studies on controlling factors
84. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4
85. Aromatase expressiion in health and disease
86. Metabolic response to severe surgical illness: Overview
87. Nutritional assessment in the critically ill
88. Postoperative protein sparing
89. Does loss of body protein determine outcome in patients who are critically ill?
90. Short-term oxandrolone administration stimulates net muscle protein synthesis in young men
91. The role of growth factors in wound healing
92. Growth factors in wound healing: The next great innovation?
93. Testosterone: The crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage
94. Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males
95. Effect of gender and sex hormones on immune responses following shock
96. Testosterone: The culprit for producing splenocyte immune depression after trauma hemorrhage
97. Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage
98. Testosterone receptor blockade after hemorrhage in males. Restoration of the depressed immune function and improved survival following subsequent sepsis
99. Effect of estradiol on endotoxin-induced changes in steroid hormone levels and lethality in male rats
100. Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals